Skip to main content


Placeholder slot

This page contains brief information about olaparib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Olaparib is approved to treat:

Olaparib is also being studied in the treatment of other types of cancer.

More About Olaparib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Olaparib - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

Trial Highlights Complexities of Targeted Therapy for Pancreatic Cancer

Olaparib after Initial Treatment Delays Ovarian Cancer Progression

Olaparib Approved for Treating Some Breast Cancers with BRCA Gene Mutations

Clinical Trial Analysis Suggests Drug Combination May be Highly Effective in Recurrent Ovarian Cancer

Targeted Cancer Therapies

FDA Approves Olaparib as Maintenance Therapy for Recurrent Ovarian Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Olaparib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: